QUEBEC CITY, Feb. 3, 2012 /PRNewswire/ - Medicago Inc. (TSX : MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing ...

QUEBEC CITY, Quebec--(BUSINESS WIRE)--Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that they have successfully produced a Virus-Like Particle (VLP) of the ...

New complex will make vaccines and therapeutics using innovative plant technology QUEBEC CITY, May 19, 2015 - Medicago, a major Canadian biotech company and an international leader in the development ...

QUEBEC CITY, Quebec--(BUSINESS WIRE)--Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that its vaccine candidate for COVID-19 induced a positive antibody response ...

Quebec City biopharmaceutical company moving towards testing stages of COVID-19 vaccine candidate QUEBEC CITY, March 23, 2020 /CNW/ - Medicago, a biopharmaceutical company headquartered in Quebec City ...

QUEBEC CITY, Feb. 5, 2013- Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing ...

Medicago said on Tuesday it has begun testing its plant-based coronavirus vaccine in an early-stage clinical trial as the Canadian company, backed by tobacco company Phillip Morris, races against ...

QUÉBEC CITY, July 12, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary ...

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy ...

A Japanese drugmaker plans to submit data for a plant-based COVID-19 vaccine to Canadian regulators. The vaccine is made using a relative of the tobacco plant. Medicago, which is making the vaccine, ...

RESEARCH TRIANGLE PARK – An ancient relative of tobacco is at the heart of a new COVID-19 vaccine under development by Medicago and GSK. The two biopharmaceutical companies are working together to ...

TORONTO — In October 2020, seven months into the coronavirus pandemic, Canadian Prime Minister Justin Trudeau told reporters he had recently spoken virtually to high school students in Ottawa. One of ...